Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arundic acid in ALS
NCT00403104Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of arundic acid in amyotrophic lateral sclerosis (ALS), sponsored by Ono Pharmaceutical. Started Nov 2006; status: completed.
02
Drugs
arundic acid
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00403104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403104.